Asubtela

Asubtela is a combined oral contraceptive containing drospirenone and ethinylestradiol. It is used for birth control and may help manage acne and premenstrual symptoms. This medication is taken orally and is manufactured by Exeltis Poland.

Asubtela is primarily used for birth control, helping to prevent pregnancy by regulating hormonal levels. It may also be prescribed to manage acne and alleviate symptoms of premenstrual dysphoric disorder (PMDD). This oral contraceptive works by preventing ovulation and altering the cervical mucus to hinder sperm movement.

Common effects of Asubtela may include changes in menstrual bleeding patterns, such as lighter or more regular periods. Some users may experience nausea, breast tenderness, or headaches. These effects vary among individuals and typically subside as the body adjusts to the medication.

Asubtela should be used with caution in individuals with a history of blood clots, high blood pressure, or liver disease. It is important to discuss any pre-existing conditions with a healthcare provider before starting this medication. Regular check-ups may be recommended to monitor for potential side effects.

Asubtela may interact with certain medications, including those metabolized by the liver's cytochrome P450 enzymes. It is advisable to avoid grapefruit products, as they can affect the metabolism of drospirenone. Always inform healthcare providers about all medications and supplements being taken to minimize the risk of interactions.